MicroRNAs Induce Epigenetic Reprogramming and Suppress Malignant Phenotypes of Human Colon Cancer Cells
暂无分享,去创建一个
H. Matsui | H. Ishii | Y. Doki | M. Mori | H. Nagano | N. Nishiyama | K. Kataoka | N. Nishida | M. Konno | J. Koseki | K. Kawamoto | Kozo Noguchi | N. Gotoh | Hirofumi Yamamoto | K. Miyata | S. Obika | H. Ogawa | Tsuyoshi Yamamoto | Xin Wu | Jun Koseki
[1] H. Ishii,et al. A Cancer Reprogramming Method Using MicroRNAs as a Novel Therapeutic Approach against Colon Cancer , 2015, Annals of Surgical Oncology.
[2] V. Findlay,et al. Epithelial to mesenchymal transition and the cancer stem cell phenotype: Insights from cancer biology with therapeutic implications for colorectal cancer , 2014, Cancer Gene Therapy.
[3] H. Eguchi,et al. Reprogramming Using microRNA-302 Improves Drug Sensitivity in Hepatocellular Carcinoma Cells , 2014, Annals of Surgical Oncology.
[4] S. Yamanaka,et al. Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation , 2014, Cell.
[5] Hsa-miR-520d induces hepatoma cells to form normal liver tissues via a stemness-mediated process , 2014, Scientific reports.
[6] K. Mimori,et al. Decreased miR-340 Expression in Bone Marrow Is Associated with Liver Metastasis of Colorectal Cancer , 2014, Molecular Cancer Therapeutics.
[7] Y. Doki,et al. Fabrication and Intracellular Delivery of Doxorubicin/Carbonate Apatite Nanocomposites: Effect on Growth Retardation of Established Colon Tumor , 2013, PloS one.
[8] P. Burridge,et al. MicroRNA‐302 Increases Reprogramming Efficiency via Repression of NR2F2 , 2013, Stem cells.
[9] M. Terry,et al. Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency based reprogramming , 2012, Oncogene.
[10] Aimee L Jackson,et al. Developing microRNA therapeutics: approaching the unique complexities. , 2012, Nucleic acid therapeutics.
[11] M. Bushell,et al. microRNAs in cancer management. , 2012, The Lancet. Oncology.
[12] L. Studer,et al. The expanding role of miR-302–367 in pluripotency and reprogramming , 2012, Cell cycle.
[13] Novel Live Alkaline Phosphatase Substrate for Identification of Pluripotent Stem Cells , 2012, Stem Cell Reviews and Reports.
[14] Mitsugu Sekimoto,et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. , 2011, Cell stem cell.
[15] Mudit Gupta,et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. , 2011, Cell stem cell.
[16] Maikun Teng,et al. MicroRNA Cluster 302–367 Enhances Somatic Cell Reprogramming by Accelerating a Mesenchymal-to-Epithelial Transition* , 2011, The Journal of Biological Chemistry.
[17] Donald C. Chang,et al. Regulation of somatic cell reprogramming through inducible mir-302 expression , 2010, Nucleic acids research.
[18] Donald C. Chang,et al. MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways. , 2010, Cancer research.
[19] T. Akaike,et al. Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[20] D. Brown,et al. The promise of microRNA replacement therapy. , 2010, Cancer research.
[21] S. Kauppinen,et al. Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection , 2010, Science.
[22] K. Mimori,et al. Defined factors induce reprogramming of gastrointestinal cancer cells , 2009, Proceedings of the National Academy of Sciences.
[23] E. Li,et al. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation , 2009, Nature Genetics.
[24] Donald C. Chang,et al. Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. , 2008, RNA.
[25] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[26] Takashi Aoi,et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts , 2008, Nature Biotechnology.
[27] T. Ichisaka,et al. Generation of germline-competent induced pluripotent stem cells , 2007, Nature.
[28] B. Perez-Ordonez,et al. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma , 2004, Journal of Clinical Pathology.